Is EXDI or JNJ a better dividend investment in 2026?

EXDI currently yields 3076.92% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: EXDI offers higher current income.

What is the dividend yield difference between EXDI and JNJ?

EXDI has a forward dividend yield of 3076.92% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 3073.56 percentage points.

Home › Compare › EXDI vs JNJ

EXDI vs JNJ: Dividend Comparison 2026

EXDI yields 3076.92% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EXDI wins by $578804600665.48M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EXDI

● Live price

3076.92%

Share price

$0.07

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$578804600665.50M

Annual income

$544,023,840,488,516,100.00

Full EXDI calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — EXDI vs JNJ

📍 EXDI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EXDI	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EXDI + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EXDI pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXDI

Annual income on $10K today (after 15% tax)

$261,538.46/yr

After 10yr DRIP, annual income (after tax)

$462,420,264,415,238,660.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, EXDI beats the other by $462,420,264,415,237,950.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXDI + JNJ for your $10,000?

EXDI: 50%JNJ: 50%

100% JNJ50/50100% EXDI

Portfolio after 10yr

$289402300332.76M

Annual income

$272,011,920,244,258,460.00/yr

Blended yield

93.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EXDI

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXDI buys

JNJ buys

No recent congressional trades found for EXDI or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEXDIJNJ

Forward yield	3076.92% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$578804600665.50M ✓	$20.0K
Annual income after 10y	$544,023,840,488,516,100.00 ✓	$827.78
Total dividends collected	$576403114825.48M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: EXDI vs JNJ ($10,000, DRIP)

Year	EXDI Portfolio	EXDI Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$318,392	$307,692.31	$10,676	$355.77	+$307.7K → EXDI
2	$9,496,461	$9,155,781.67	$11,407	$389.39	+$9.49M → EXDI
3	$265,378,974	$255,217,760.17	$12,198	$426.53	+$265.37M → EXDI
4	$6,949,441,440	$6,665,485,937.77	$13,056	$467.62	+$6949.43M → EXDI
5	$170,564,997,752	$163,129,095,411.51	$13,987	$513.12	+$170564.98M → EXDI
6	$3,924,365,658,393	$3,741,861,110,798.54	$14,998	$563.56	+$3924365.64M → EXDI
7	$84,659,703,250,880	$80,460,631,996,399.20	$16,098	$619.52	+$84659703.23M → EXDI
8	$1,712,795,370,094,185	$1,622,209,487,615,743.00	$17,295	$681.69	+$1712795370.08M → EXDI
9	$32,505,383,342,974,930	$30,672,692,296,974,148.00	$18,599	$750.82	+$32505383342.96M → EXDI
10	$578,804,600,665,499,400	$544,023,840,488,516,100.00	$20,022	$827.78	+$578804600665.48M → EXDI

EXDI vs JNJ: Complete Analysis 2026

EXDI — Stock

Exactus, Inc. produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The company's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company is based in Delray Beach, Florida. Exactus, Inc. is a subsidiary of Ceed2Med, LLC.

Full EXDI Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this EXDI vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXDI vs SCHD EXDI vs JEPI EXDI vs O EXDI vs KO EXDI vs MAIN EXDI vs ABBV EXDI vs MRK EXDI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.